81 FR 33263 - Submission for OMB Review; 30-Day Comment Request; Surveys and Interviews To Support an Evaluation of the Innovative Molecular Analysis Technologies (IMAT) Program (NCI)
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health Federal Register Volume 81, Issue 101 (May 25, 2016)
National Institutes of Health
Federal Register Volume 81, Issue 101 (May 25, 2016)
| Page Range | 33263-33264 | |
| FR Document | 2016-12294 |
[Federal Register Volume 81, Number 101 (Wednesday, May 25, 2016)] [Notices] [Pages 33263-33264] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2016-12294] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Submission for OMB Review; 30-Day Comment Request; Surveys and Interviews To Support an Evaluation of the Innovative Molecular Analysis Technologies (IMAT) Program (NCI) SUMMARY: Under the provisions of Section 3507(a)(1)(D) of the Paperwork Reduction Act of 1995, the National Cancer Institute, the National Institutes of Health, has submitted to the Office of Management and Budget (OMB) a request for review and approval of the information collection listed below. This proposed information collection was previously published in the Federal Register on March 23, 2016, Vol. 81, Page 15541 and allowed 60-days for public comment. The purpose of this notice is to allow an additional 30 days for public comment. The National Cancer Institute (NCI), National Institutes of Health, may not conduct or sponsor, and the respondent is not required to respond to, an information collection that has been extended, revised, or implemented on or after October 1, 1995, unless it displays a currently valid OMB control number. Direct Comments to OMB: Written comments and/or suggestions regarding the item(s) contained in this notice, especially regarding the estimated public burden and associated response time, should be directed to the: Office of Management and Budget, Office of Regulatory Affairs, [email protected] or by fax to 202-395-6974, Attention: NIH Desk Officer. Comment Due Date: Comments regarding this information collection are best assured of having their full effect if received within 30 days of the date of this publication. FOR FURTHER INFORMATION CONTACT: To obtain a copy of the data collection plans and instruments, or request more information on the proposed project, contact: Anthony Dickherber, NCI Center for Strategic Scientific Initiatives, 31 Center Drive, Rm10A33, Bethesda, MD 20892 or call non-toll-free number 301-547-9980 or Email your request, including your address to: [email protected]. Formal requests for additional plans and instruments must be requested in writing. Proposed Collection: Surveys and Interviews to Support an Evaluation of the Innovative Molecular Analysis Technologies (IMAT) Program (NCI), 0925-0720, Expiration Date 5/31/2016--EXTENSION, National Cancer Institute (NCI), National Institutes of Health (NIH). Need and Use of Information Collection: The purpose of the proposed evaluation is to pursue a comprehensive process and outcome assessment of the 15-year old Innovative Molecular Analysis Technologies (IMAT) program. While the program consistently offers promising indicators of success, the full program has not been evaluated since 2008, and never in as comprehensive a manner as has been formulated in the current evaluation plan. An outcome evaluation of the long-standing National Cancer Institute's (NCI) IMAT program presents a rich and unique opportunity likely to serve institutes across the National Institutes of Health (NIH), and perhaps other federal agencies, considering the costs and benefits of directing resources towards supporting technology development. An award through the NIH Evaluation Set-Aside program to support this evaluation, for which NIH-wide relevance is a principle element of determining merit for support, is testament to this. The evaluation serves as an opportunity to gauge the impact of investments in technology development and also to assess the strengths and weaknesses of phased innovation award mechanisms. Prior approval from OMB allowed for extensive surveys and interviews already, and this extension is requested to accommodate unforeseen delays in collecting the remaining information. Like all institutes and centers (ICs) of the NIH, NCI seeks opportunities for improving their programs' utility for the broad continuum of researchers, clinicians and ultimately patients. NCI Acting Director Douglas Lowy and other leadership across NCI, as well as the NCI Board of Scientific Advisors, will be the primary users of the evaluation results. Findings are primarily intended for considering the long-term strategy to support innovative technology development and how to more efficiently translate emerging capabilities through such technologies into the promised benefits for cancer research and clinical care. Interviews with grantees, program officers, review officers, and other NIH awardees make up a crucial component of the evaluation plan and will largely follow set survey protocols. Specific near-term aims include the use of this information to consider the utility of continued investment through existing solicitations and in strategic planning generally for institute support for innovative technology development. OMB approval is requested for 1 year. There are no costs to respondents other than their time. The total estimated annualized burden hours are 233. Estimated Annualized Burden Hours ---------------------------------------------------------------------------------------------------------------- Number of Average burden Total annual Form name Type of Number of responses per per response burden (in respondents respondents respondent (in hours) hours) ---------------------------------------------------------------------------------------------------------------- Interview--IMAT Grantee....... IMAT Awardees... 18 1 1 18 Web-based Survey--Technology IMAT Awardees; 379 1 30/60 190 Grantees. Other NIH Awardees representing comparison group. Interview--Tech End-Users..... Technology End- 50 1 30/60 25 Users. --------------------------------------------------------------- Totals.................... ................ 447 447 .............. 233 ---------------------------------------------------------------------------------------------------------------- [[Page 33264]] Dated: May 19, 2016. Karla Bailey, Project Clearance Liaison, National Cancer Institute, NIH. [FR Doc. 2016-12294 Filed 5-24-16; 8:45 am] BILLING CODE 4140-01-P
![Federal Register / Vol. 81, No. 101 / Wednesday, May 25, 2016 / Notices 33263
Correction revised, or implemented on or after presents a rich and unique opportunity
In the Federal Register of April 27, October 1, 1995, unless it displays a likely to serve institutes across the
2016, in FR Doc. 2016–09812, the currently valid OMB control number. National Institutes of Health (NIH), and
following corrections are made: Direct Comments to OMB: Written perhaps other federal agencies,
comments and/or suggestions regarding considering the costs and benefits of
1. On page 24828, in the first column,
the item(s) contained in this notice, directing resources towards supporting
under the heading ‘‘Key Dates’’, the
especially regarding the estimated technology development. An award
correct Earliest Anticipated Start Date
public burden and associated response through the NIH Evaluation Set-Aside
should read as ‘‘Earliest Anticipated
time, should be directed to the: Office program to support this evaluation, for
Start Date: August 15, 2016’’.
of Management and Budget, Office of which NIH-wide relevance is a principle
2. On page 24829, in the first column,
Regulatory Affairs, OIRA_submission@ element of determining merit for
under the heading ‘‘Project Period’’, the
omb.eop.gov or by fax to 202–395–6974, support, is testament to this. The
correct paragraph should read as ‘‘The
Attention: NIH Desk Officer. evaluation serves as an opportunity to
project period will be for three (3) years
Comment Due Date: Comments gauge the impact of investments in
and will run consecutively from August
regarding this information collection are technology development and also to
15, 2016 to August 14, 2019’’.
best assured of having their full effect if assess the strengths and weaknesses of
Dated: May 11, 2016. received within 30 days of the date of phased innovation award mechanisms.
Elizabeth A. Fowler, this publication. Prior approval from OMB allowed for
Deputy Director for Management Operations, FOR FURTHER INFORMATION CONTACT: To extensive surveys and interviews
Indian Health Service. obtain a copy of the data collection already, and this extension is requested
[FR Doc. 2016–12303 Filed 5–24–16; 8:45 am] plans and instruments, or request more to accommodate unforeseen delays in
BILLING CODE 4165–16–P information on the proposed project, collecting the remaining information.
contact: Anthony Dickherber, NCI Like all institutes and centers (ICs) of
Center for Strategic Scientific Initiatives, the NIH, NCI seeks opportunities for
DEPARTMENT OF HEALTH AND 31 Center Drive, Rm10A33, Bethesda, improving their programs’ utility for the
HUMAN SERVICES MD 20892 or call non-toll-free number broad continuum of researchers,
301–547–9980 or Email your request, clinicians and ultimately patients. NCI
National Institutes of Health including your address to: Acting Director Douglas Lowy and other
Submission for OMB Review; 30-Day dickherberaj@mail.nih.gov. Formal leadership across NCI, as well as the
Comment Request; Surveys and requests for additional plans and NCI Board of Scientific Advisors, will
Interviews To Support an Evaluation of instruments must be requested in be the primary users of the evaluation
the Innovative Molecular Analysis writing. results. Findings are primarily intended
Technologies (IMAT) Program (NCI) Proposed Collection: Surveys and for considering the long-term strategy to
Interviews to Support an Evaluation of support innovative technology
SUMMARY: Under the provisions of the Innovative Molecular Analysis development and how to more
Section 3507(a)(1)(D) of the Paperwork Technologies (IMAT) Program (NCI), efficiently translate emerging
Reduction Act of 1995, the National 0925–0720, Expiration Date 5/31/2016— capabilities through such technologies
Cancer Institute, the National Institutes EXTENSION, National Cancer Institute into the promised benefits for cancer
of Health, has submitted to the Office of (NCI), National Institutes of Health research and clinical care. Interviews
Management and Budget (OMB) a (NIH). with grantees, program officers, review
request for review and approval of the Need and Use of Information officers, and other NIH awardees make
information collection listed below. Collection: The purpose of the proposed up a crucial component of the
This proposed information collection evaluation is to pursue a comprehensive evaluation plan and will largely follow
was previously published in the Federal process and outcome assessment of the set survey protocols. Specific near-term
Register on March 23, 2016, Vol. 81, 15-year old Innovative Molecular aims include the use of this information
Page 15541 and allowed 60-days for Analysis Technologies (IMAT) program. to consider the utility of continued
public comment. The purpose of this While the program consistently offers investment through existing
notice is to allow an additional 30 days promising indicators of success, the full solicitations and in strategic planning
for public comment. The National program has not been evaluated since generally for institute support for
Cancer Institute (NCI), National 2008, and never in as comprehensive a innovative technology development.
Institutes of Health, may not conduct or manner as has been formulated in the OMB approval is requested for 1 year.
sponsor, and the respondent is not current evaluation plan. An outcome There are no costs to respondents other
required to respond to, an information evaluation of the long-standing National than their time. The total estimated
collection that has been extended, Cancer Institute’s (NCI) IMAT program annualized burden hours are 233.
ESTIMATED ANNUALIZED BURDEN HOURS
Average
Number of Total annual
Number of burden per
Form name Type of respondents responses per burden
respondents response
respondent (in hours)
(in hours)
mstockstill on DSK3G9T082PROD with NOTICES
Interview—IMAT Grantee ................. IMAT Awardees ................................ 18 1 1 18
Web-based Survey—Technology IMAT Awardees; Other NIH Award- 379 1 30/60 190
Grantees. ees representing comparison
group.
Interview—Tech End-Users .............. Technology End-Users ..................... 50 1 30/60 25
Totals ......................................... ........................................................... 447 447 ........................ 233
VerDate Sep<11>2014 20:19 May 24, 2016 Jkt 238001 PO 00000 Frm 00066 Fmt 4703 Sfmt 4703 E:\FR\FM\25MYN1.SGM 25MYN1](https://thefederalregister.org/doc/81_FR_33364/page/1.svg)
![33264 Federal Register / Vol. 81, No. 101 / Wednesday, May 25, 2016 / Notices
Dated: May 19, 2016. Time: 8:00 a.m. to 5:30 p.m. Name of Committee: Center for Scientific
Karla Bailey, Agenda: To review and evaluate grant Review Special Emphasis Panel;
applications. Collaborative Applications: Adult
Project Clearance Liaison, National Cancer
Place: Sheraton La Jolla Hotel, 3299 Psychopathology.
Institute, NIH.
Holiday Court, La Jolla, CA 92037. Date: June 24, 2016.
[FR Doc. 2016–12294 Filed 5–24–16; 8:45 am] Contact Person: Gagan Pandya, Ph.D., Time: 1:00 p.m. to 1:30 p.m.
BILLING CODE 4140–01–P Scientific Review Officer, National Institutes Agenda: To review and evaluate grant
of Health, Center for Scientific Review, 6701 applications.
Rockledge Drive, RM 3200, MSC 7808, Place: Marines’ Memorial Club and Hotel,
DEPARTMENT OF HEALTH AND Bethesda, MD 20892, 301–435–1167, 609 Sutter Street, San Francisco, CA 94102.
HUMAN SERVICES pandyaga@mail.nih.gov. Contact Person: Serena Chu, Ph.D.,
Name of Committee: Center for Scientific Scientific Review Officer, BBBP IRG, Center
National Institutes of Health Review Special Emphasis Panel; Topics in for Scientific Review, National Institutes of
Non-HIV Microbial Diagnostic and Detection Health, 6701 Rockledge Drive, Room 3178,
Center for Scientific Review; Notice of Research. MSC 7848, Bethesda, MD 20892, 301–500–
Date: June 24, 2016. 5829, sechu@csr.nih.gov.
Closed Meetings
Time: 8:00 a.m. to 5:00 p.m. Name of Committee: Center for Scientific
Pursuant to section 10(d) of the Agenda: To review and evaluate grant Review Special Emphasis Panel; PAR Panel:
Federal Advisory Committee Act, as applications. Alzheimer’s Disease Pilot Clinical Trials.
amended (5 U.S.C. App.), notice is Place: Sheraton La Jolla Hotel, 3299 Date: June 24, 2016.
hereby given of the following meetings. Holiday Court, La Jolla, CA 92037. Time: 1:00 p.m. to 5:00 p.m.
The meetings will be closed to the Contact Person: Gagan Pandya, Ph.D., Agenda: To review and evaluate grant
Scientific Review Officer, National Institutes applications.
public in accordance with the of Health, Center for Scientific Review, 6701 Place: National Institutes of Health, 6701
provisions set forth in sections Rockledge Drive, RM 3200, MSC 7808, Rockledge Drive, Bethesda, MD 20892,
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Bethesda, MD 20892, 301–435–1167, (Telephone Conference Call).
as amended. The grant applications and pandyaga@mail.nih.gov. Contact Person: Mark Lindner, Ph.D.,
the discussions could disclose Name of Committee: Center for Scientific Scientific Review Officer, Center for
confidential trade secrets or commercial Review Special Emphasis Panel; Small Scientific Review, National Institutes of
property such as patentable material, Business: Innovative Immunology Research. Health, 6701 Rockledge Drive, Room 3182,
Date: June 24, 2016. MSC 7770, Bethesda, MD 20892, 301–915–
and personal information concerning 6298, mark.lindner@csr.nih.gov.
individuals associated with the grant Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant (Catalogue of Federal Domestic Assistance
applications, the disclosure of which Program Nos. 93.306, Comparative Medicine;
applications.
would constitute a clearly unwarranted Place: Renaissance Arlington Capital View 93.333, Clinical Research, 93.306, 93.333,
invasion of personal privacy. Hotel, 2800 South Potomac Ave., Arlington, 93.337, 93.393–93.396, 93.837–93.844,
Name of Committee: Population Sciences VA 22202. 93.846–93.878, 93.892, 93.893, National
and Epidemiology Integrated Review Group; Contact Person: Deborah Hodge, Ph.D., Institutes of Health, HHS)
Cancer, Heart, and Sleep Epidemiology B Scientific Review Officer, Center for Dated: May 19, 2016.
Study Section. Scientific Review, National Institutes of
Carolyn Baum,
Date: June 16–17, 2016. Health, 6701 Rockledge Drive, Room 4207
Time: 8:00 a.m. to 3:00 p.m. MSC 7812, Bethesda, MD 20892, (301)435– Program Analyst, Office of Federal Advisory
Agenda: To review and evaluate grant 1238, hodged@mail.nih.gov. Committee Policy.
applications. Name of Committee: Center for Scientific [FR Doc. 2016–12295 Filed 5–24–16; 8:45 am]
Place: Embassy Suites at the Chevy Chase Review Special Emphasis Panel; Microbiome BILLING CODE 4140–01–P
Pavilion, 4300 Military Rd. NW., and Related Sciences.
Washington, DC 20015. Date: June 24, 2016.
Contact Person: Ellen K Schwartz, EDD, Time: 10:30 a.m. to 2:00 p.m. DEPARTMENT OF HEALTH AND
Scientific Review Officer, Center for Agenda: To review and evaluate grant HUMAN SERVICES
Scientific Review, National Institutes of applications.
Health, 6701 Rockledge Drive, Room 3144, Place: Courtyard by Marriott Downtown National Institutes of Health
MSC 7770, Bethesda, MD 20892, 301–828– Silver Spring, 8506 Fenton Street, Fenton
6146, schwarel@mail.nih.gov. Street, Silver Spring, MD 20910. National Institute of Mental Health;
Name of Committee: Center for Scientific Contact Person: Aiping Zhao, MD, Notice of Closed Meetings
Review Special Emphasis Panel; Member Scientific Review Officer, Center for
Conflict: Psychosocial Risks and Disease Scientific Review, National Institutes of Pursuant to section 10(d) of the
Prevention. Health, 6701 Rockledge Drive, Rm 2188 Federal Advisory Committee Act, as
Date: June 21, 2016. MSC7818, Bethesda, MD 20892–7818, (301) amended (5 U.S.C. App.), notice is
Time: 1:00 p.m. to 4:00 p.m. 435–0682, zhaoa2@csr.nih.gov. hereby given of the following meetings.
Agenda: To review and evaluate grant Name of Committee: Center for Scientific The meetings will be closed to the
applications. Review Special Emphasis Panel; PAR13–231:
Place: National Institutes of Health, 6701
public in accordance with the
Phenotyping Embryonic Lethal Knockout provisions set forth in sections
Rockledge Drive, Bethesda, MD 20892, Mice.
(Virtual Meeting). Date: June 24, 2016. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
Contact Person: Weijia Ni, Ph.D., Chief/ Time: 1:00 p.m. to 3:00 p.m. as amended. The grant applications and
Scientific Review Officer, Center for Agenda: To review and evaluate grant the discussions could disclose
Scientific Review, National Institutes of applications. confidential trade secrets or commercial
Health, 6701 Rockledge Drive, Room 3100, Place: National Institutes of Health, 6701 property such as patentable material,
mstockstill on DSK3G9T082PROD with NOTICES
MSC 7808, Bethesda, MD 20892, 301–594– Rockledge Drive, Bethesda, MD 20892, and personal information concerning
3292, niw@csr.nih.gov. (Telephone Conference Call). individuals associated with the grant
Name of Committee: Center for Scientific Contact Person: Maqsood A Wani, Ph.D., applications, the disclosure of which
Review Special Emphasis Panel; Small Scientific Review Officer, Center for
would constitute a clearly unwarranted
Business: Non-HIV Diagnostics, Food Safety, Scientific Review, National Institutes of
Sterilization/Disinfection, and Health, 6701 Rockledge Drive, Room 2114, invasion of personal privacy.
Bioremediation. MSC 7814, Bethesda, MD 20892, 301–435– Name of Committee: National Institute of
Date: June 23–24, 2016. 2270, wanimaqs@csr.nih.gov. Mental Health Special Emphasis Panel;
VerDate Sep<11>2014 20:19 May 24, 2016 Jkt 238001 PO 00000 Frm 00067 Fmt 4703 Sfmt 4703 E:\FR\FM\25MYN1.SGM 25MYN1](https://thefederalregister.org/doc/81_FR_33364/page/2.svg)
Document Created: 2018-02-07 15:03:36
Document Modified: 2018-02-07 15:03:36
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Dates | Comments regarding this information collection are best assured of having their full effect if received within 30 days of the date of this publication. | |
| Contact | To obtain a copy of the data collection plans and instruments, or request more information on the proposed project, contact: Anthony Dickherber, NCI Center for Strategic Scientific Initiatives, 31 Center Drive, Rm10A33, Bethesda, MD 20892 or call non-toll-free number 301-547-9980 or Email your request, including | |
| FR Citation | 81 FR 33263 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR